Cargando…
Doxorubicin induced heart failure: Phenotype and molecular mechanisms
Long term survival of childhood cancers is now more than 70%. Anthracyclines, including doxorubicin, are some of the most efficacious anticancer drugs available. However, its use as a chemotherapeutic agent is severely hindered by its dose-limiting toxicities. Most notably observed is cardiotoxicity...
Autores principales: | Mitry, Maria A., Edwards, John G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871279/ https://www.ncbi.nlm.nih.gov/pubmed/27213178 http://dx.doi.org/10.1016/j.ijcha.2015.11.004 |
Ejemplares similares
-
Exploration the Mechanism of Doxorubicin-Induced Heart Failure in Rats by Integration of Proteomics and Metabolomics Data
por: Yuan, Yu, et al.
Publicado: (2020) -
Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin
por: Yokoyama, Chiharu, et al.
Publicado: (2016) -
Oxidative Stress and Pyroptosis in Doxorubicin-Induced Heart Failure and Atrial Fibrillation
por: Ping, Zhang, et al.
Publicado: (2023) -
Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure
por: Lewalle, Alexandre, et al.
Publicado: (2019) -
Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
por: Ono, Masaya, et al.
Publicado: (2021)